Table 3.
Comparison of Serum Concentration of Cathelicidin in Children with IBD in Terms of Disease Activity and Controls
| Parameters | Groups | Mean | SD | Median | Range | Statistical Analysis |
|---|---|---|---|---|---|---|
| Cathelicidin [ng/mL] | Active Crohn’s disease (n=16) | 1054.54 | 188.41 | 1038.22 | 742.31–1473.33 | *†‡¥ |
| Inactive Crohn’s disease (n=9) | 1063.12 | 162.33 | 1040.04 | 797.36–1272.40 | ||
| Active ulcerative colitis (n=23) | 1038.20 | 171.15 | 1042.93 | 621.38–1372.95 | ||
| Inactive ulcerative colitis (n=20) | 1113.85 | 254.13 | 1121.35 | 719.71–2028.39 | ||
| Controls (n=20) | 890.56 | 129.37 | 918.47 | 616.46–1091.76 |
Notes: *Z=2.43 p=0.01 when comparing active Crohn’s disease to controls; †Z=−2.62 p=0.009 when comparing inactive Crohn’s disease to controls; ‡Z=3.01 p=0.002 when comparing active ulcerative colitis to controls; ¥Z=−3.96 p<0.0001 when comparing inactive ulcerative colitis to controls.